Red Ginseng Extract With Climacteric Symptoms

A 24-week, Single-center, Open-label Study to Evaluate Gut Microbiota, Immunity, Oxidative Stress and Autonomic Nerve System of Red Ginseng Extract in Subjects With Climacteric Symptoms.

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03865745

Enrollment

Registered

2019-03-07

Start date

2019-03-31

Completion date

2020-02-29

Last updated

2019-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Climacteric Symptoms

Brief summary

The purpose of this study is to investigate the positive effects of red ginseng extract on intestinal bacterial changes and immunity, free radicals, antioxidant capacity, and autonomic nervous system changes in age of 40\ 75 men and women with climacteric symptoms for 24 weeks.

Detailed description

A screening test is conducted for those who have agreed in writing with a detailed explanation of the purpose of this study and research methods, and then a person who meets the selection / exclusion criteria is selected. Give a registration number to the person selected as the subject through the screening, and take one pack of the product (3g) once a day for 24 weeks in a human body application test. Prior to taking the registration number (1Day), the efficacy evaluation items and the safety evaluation items are carried out. At the 24 weeks after the starting point of taking the product of human application test, the evaluation items are conducted through outpatient visits.

Interventions

DIETARY_SUPPLEMENTKorean Red Ginseng

Take one pack of the product (3g) once a day for 24 weeks

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

40 Years to 75 Years

Healthy volunteers

Inclusion criteria

1. Age of 40\ 75 men and women 2. Those who visited the menopausal clinic with complaints of climacteric symptoms due to functional deterioration of various organs such as fatigue, helplessness 3. Those who have agreed to voluntarily decide to participate and observe the instructions after hearing the detailed explanation of this human body application test

Exclusion criteria

1. Those who have suspected symptoms of acute disease (severe infectious disease, severe trauma, severe diarrhea, vomiting, etc.) 2. Patients with a history of antibiotic treatment for more than 1 month within the last 6 months 3. Those who have gastrointestinal diseases (inflammatory growth disease, active peptic ulcer, etc.) or gastrointestinal surgery (except for simple appendectomy or hernia surgery) 4. Those taking health functional foods, lactic acid bacteria, and red ginseng extracts for the past year 5. Those who are currently participating in other clinical studies or human trials, or participating in clinical trials or human application tests within the past month

Design outcomes

Primary

Measure	Time frame
Changes in gut microbiota at 24 weeks vs baseline	24 weeks

Secondary

Measure	Time frame
Changes in Total Oxidant Status(TOS in µmol/L) at 24 weeks vs baseline	24 weeks
Changes in Total Antioxidant Status(TAS in mmol/L) at 24 weeks vs baseline	24 weeks
Changes in Natural Killer(NK) cell activity at 24 weeks vs baseline	24 weeks
Changes in Heart rate variability at 24 weeks vs baseline	24 weeks

Contacts

Primary ContactYoun Ju Lee

yj.lee@mediex.co.kr82-2-3482-7834

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026